12/4
08:36 am
maze
Rating for MAZE
Low
Report
Rating for MAZE
12/4
08:36 am
maze
Rating for MAZE
Low
Report
Rating for MAZE
12/4
05:32 am
maze
Maze Therapeutics initiated with an Overweight at Wells Fargo
Low
Report
Maze Therapeutics initiated with an Overweight at Wells Fargo
12/4
05:32 am
maze
Maze Therapeutics initiated with an Overweight at Wells Fargo
Low
Report
Maze Therapeutics initiated with an Overweight at Wells Fargo
12/3
10:09 am
maze
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/15
10:33 am
maze
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
Medium
Report
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
11/13
06:12 pm
maze
Maze Therapeutics (NASDAQ:MAZE) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
11/7
10:05 am
maze
Rating for MAZE
Low
Report
Rating for MAZE
11/7
10:05 am
maze
Rating for MAZE
Low
Report
Rating for MAZE
9/29
08:51 am
maze
Rating for MAZE
Medium
Report
Rating for MAZE
9/18
08:09 am
maze
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
9/15
08:39 am
maze
Rating for MAZE
Low
Report
Rating for MAZE
9/15
08:39 am
maze
Rating for MAZE
Low
Report
Rating for MAZE
9/12
07:01 am
maze
Rating for MAZE
Medium
Report
Rating for MAZE